Loading…
Fractyl Health, Inc. is projected to rise to $0.7958 by 2027, a +16% move from its current price of $0.685. GUTS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.6562 | $0.6856 | $0.7164 | +0.09% |
| Aug 6 | $0.6449 | $0.6863 | $0.7303 | +0.19% |
| Aug 7 | $0.6366 | $0.6869 | $0.7413 | +0.28% |
| Aug 8 | $0.6297 | $0.6876 | $0.7507 | +0.38% |
| Aug 9 | $0.6238 | $0.6882 | $0.7593 | +0.47% |
| Aug 10 | $0.6186 | $0.6889 | $0.7672 | +0.57% |
| Aug 11 | $0.6138 | $0.6895 | $0.7745 | +0.66% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6138 | $0.6895 | $0.7745 | +0.66% |
| Week 2 | $0.5888 | $0.6941 | $0.8181 | +1.33% |
| Week 3 | $0.5712 | $0.6987 | $0.8545 | +2.00% |
| Week 4 | $0.5574 | $0.7033 | $0.8874 | +2.67% |
| Week 5 | $0.5459 | $0.7079 | $0.9181 | +3.35% |
| Week 6 | $0.536 | $0.7126 | $0.9474 | +4.03% |
| Week 7 | $0.5274 | $0.7173 | $0.9757 | +4.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fractyl Health, Inc. is a healthcare company focused on metabolic therapeutics. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc.
and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Fractyl Health, Inc. trades under the symbol GUTS. It is a healthcare stock with a current price of $0.7226 and a market capitalization of $114.64M. Its market rank is 3948.
Key near-term metrics include a 30-day range of $0.5341 to $0.9777 and an annualized volatility of 90%.
The 30-day technical picture shows neutral sentiment with RSI14 at 50, SMA50 at $0.8093, and SMA200 at $1.05; the price has support at $0.724 and resistance at $0.91.
Forecast outlook suggests the 2026 average price is $0.7226, with a bullish path through 2027–2050. The sequence includes 2027 avg $0.8896; 2028 avg $1.19; 2029 avg $1.60; 2030 avg $2.15; 2031 avg $2.25; 2032 avg $2.15; 2033 avg $2.71; 2034 avg $2.82; 2035 avg $3.48; 2040 avg $4.87; 2050 avg $14.46, with corresponding 30-year max up to $33.25 and 2030 max $3.55, 2040 max $9.97 and 2050 max $33.25. ROI figures rise from 0 in 2026 to 23.1 in 2027, 64.4 in 2028, 121.5 in 2029, 197.6 in 2030, and 1900.8 in 2050, all in bullish terms.
A major floor 37.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 32.8% above — a clean break opens room to run.
A major ceiling 43.8% above — clearing it would confirm fresh momentum.
Key GUTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GUTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7178 | Sell | $0.7101 | Sell |
| MA 10 | $0.7429 | Sell | $0.7362 | Sell |
| MA 20 | $0.7757 | Sell | $0.7598 | Sell |
| MA 50 | $0.7928 | Sell | $0.7674 | Sell |
| MA 100 | $0.6854 | Sell | $0.8044 | Sell |
| MA 200 | $1.04 | Sell | $1.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.55 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -156.65 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -24.73 | Sell |
| Bollinger %B (20,2) | 0.07 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 33.15 | Neutral |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 0.68 | Buy |
| ADX (14) | 10.41 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day picture is neutral, with RSI14 at 50 and the stock trading around key moving averages. SMA50 is $0.8093 and SMA200 is $1.05, placing near-term price action within a band between support and resistance. The near-term range is $0.5341 to $0.9777, with a current price of $0.7226 and near-term support at $0.724 and resistance at $0.91.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.393 | $0.685 | $0.9496 | 0% | Neutral | |
| $0.5997 | $0.7958 | $1.13 | +16% | Neutral | |
| $0.7229 | $1.01 | $1.52 | +47% | Bullish | |
| $0.8911 | $1.29 | $2.04 | +89% | Bullish | |
| $1.15 | $1.73 | $2.82 | +153% | Bullish | |
| $1.16 | $1.81 | $3.04 | +164% | Bullish | |
| $1.05 | $1.68 | $2.91 | +146% | Bullish | |
| $1.24 | $2.06 | $3.65 | +201% | Bullish | |
| $1.24 | $2.11 | $3.82 | +208% | Bullish | |
| $1.41 | $2.48 | $4.59 | +263% | Bullish | |
| $1.71 | $3.42 | $6.88 | +400% | Bullish | |
| $4.26 | $9.47 | $21.45 | +12.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.393 | $0.685 | $0.8138 | +0.00% |
| September 2026 | $0.5768 | $0.6943 | $0.8678 | +1.36% |
| October 2026 | $0.6131 | $0.7464 | $0.9486 | +7.49% |
| November 2026 | $0.6038 | $0.7418 | $0.9557 | -0.60% |
| December 2026 | $0.5878 | $0.7283 | $0.9496 | -1.82% |
Click any year to see its month-by-month GUTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GUTS to range from $0.393 to $0.9496 through 2026. The $0.685 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GUTS price prediction for 2027 points to an average of $0.7958 (low $0.5997, high $1.13) — a potential gain of +16% on today's $0.685. A consolidation phase looks the most probable path here.
In 2028, GUTS is projected to trade between $0.7229 and $1.52, averaging $1.01 — a potential gain of +47% from today's $0.685. That is up +27% on the projected 2027 average. Momentum favours further upside here.
Fractyl Health, Inc.'s 2029 outlook centres on $1.29, within a $0.8911 to $2.04 range. That is up +28% on the projected 2028 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GUTS could reach as high as $2.82, with a base case around $1.73 and support toward $1.15 — roughly +153% from $0.685. Momentum favours further upside here.
Expect GUTS to range from $1.16 to $3.04 through 2031. The $1.81 average target implies a +164% move from current prices. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The GUTS price prediction for 2032 points to an average of $1.68 (low $1.05, high $2.91) — a potential gain of +146% on today's $0.685. Momentum favours further upside here.
In 2033, GUTS is projected to trade between $1.24 and $3.65, averaging $2.06 — a potential gain of +201% from today's $0.685. That is up +22% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Fractyl Health, Inc.'s 2034 outlook centres on $2.11, within a $1.24 to $3.82 range. That is up +2% on the projected 2033 average. That marks a +208% change versus current levels. Momentum favours further upside here.
By 2035, GUTS could reach as high as $4.59, with a base case around $2.48 and support toward $1.41 — roughly +263% from $0.685. Buyers look set to stay in control over this stretch.
Expect GUTS to range from $1.71 to $6.88 through 2040. The $3.42 average target implies a +400% move from current prices. That is up +38% on the projected 2035 average. Momentum favours further upside here.
The GUTS price prediction for 2050 points to an average of $9.47 (low $4.26, high $21.45) — a potential gain of +12.8x on today's $0.685. Buyers look set to stay in control over this stretch.
Investing $1,000 in GUTS today (≈ 1,459.854015 GUTS) could be worth
$13,817.59
+$12,817.59 (+1282%) by 2050 · US Dollar
Based on the average projected GUTS price of $9.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GUTSwould be worth at today's price.
$1,000 invested in GUTS on Jul 31, 2025 (≈ 543.478251 GUTS) would be worth
$372.28
-$627.72 (-62.8%) today · 0.37× · US Dollar
Based on a GUTS entry price of $1.84 vs. today's $0.685.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.773 | $886.16 | -11.4% |
| 1 month ago | $0.783 | $874.84 | -12.5% |
| 3 months ago | $0.699 | $979.97 | -2.0% |
| 6 months ago | $0.472 | $1,451.27 | +45.1% |
| 1 year ago | $1.84 | $372.28 | -62.8% |
| All time (2.5y) ago | $12.85 | $53.31 | -94.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GUTS forecast.
Our base-case forecast reaches $1.40 around 2030.
Implied market cap at $1.40: $222.11M
The multi-year forecast leans bullish from 2027 onward, with the 2026 average price at $0.7226 and an upward trajectory through 2030, 2040, and 2050. By 2030, the average price is $2.15 (min $1.41; max $3.55) with a forecasted ROI of 197.6 and bullish sentiment. By 2040, the average price is $4.87 (min $2.35; max $9.97) with a forecasted ROI of 574 and bullish sentiment.
By 2050, the average price is $14.46 (min $6.51; max $33.25) with a forecasted ROI of 1900.8 and bullish sentiment. These are estimates, not guarantees, and actual results may differ from the projections.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $2.15 (min $1.41, max $3.55) with a forecasted ROI of 197.6 and a bullish sentiment.
The forecast indicates bullish sentiment from 2027 onward, with the average price rising to $14.46 by 2050 and a 2050 ROI of 1900.8. These are estimates, not guarantees.
The 2050 max price is $33.25, with the 2050 average $14.46, and the 2040 max $9.97. Reaching $10 appears possible within the forecast path, but is not guaranteed.
The current price is $0.7226. The 2026 forecast average is $0.7226, with a bullish path projected for later years.
These are estimates and not guarantees. The forecast shows bullish momentum in later years, but actual results may differ.
Fractyl Health, Inc. Community Discussion
0Share your Fractyl Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.